Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 799.21% | -111.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 799.21% | -111.20% | |||
| Cost of Revenue | 169.73% | -181.92% | |||
| Gross Profit | 90.86% | -49.24% | |||
| SG&A Expenses | 143.19% | -61.08% | |||
| Depreciation & Amortization | 23,300.00% | -99.67% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 623.06% | -114.97% | |||
| Operating Income | -187.88% | 188.90% | |||
| Income Before Tax | -128.13% | 189.14% | |||
| Income Tax Expenses | 110.69% | -367.86% | |||
| Earnings from Continuing Operations | -126.76% | 198.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -103.60% | 831.59% | |||
| EBIT | -187.88% | 188.90% | |||
| EBITDA | -93.98% | 263.96% | |||
| EPS Basic | -103.56% | 823.85% | |||
| Normalized Basic EPS | -128.02% | 188.46% | |||
| EPS Diluted | -103.70% | 795.66% | |||
| Normalized Diluted EPS | -128.86% | 185.90% | |||
| Average Basic Shares Outstanding | 1.04% | 1.03% | |||
| Average Diluted Shares Outstanding | -1.87% | 4.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||